Product Name: EDG7 antibody
Applications: IHC, IHC-P
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Affinity purified with antigen
Full Name: lysophosphatidic acid receptor 3
Background: EDG7, a Lysophospholipid/Lysosphingolipid Receptor, was identified by RT-PCR from Jurkat T-cells. It is activated by unsaturated lysophosphatidic acid LPA. EDG7 has been reported in human prostate, as well as rodent brain, kidney, lung, placenta, prostate, and testis. ESTs have been isolated from a normal prostate library, as well as cancer libraries of the head/neck, ovary, and thyroid.
Synonyms: 605106, EDG7, RP4-678I3, Q9UBY5, 23566, GPCR, RP4678I3, LP-A3, Edg-7, HOFNH30, LPAR3, LPA3, LP A3, Edg 7
Cellular Localization:
CAS NO: 1065559-56-9
Product: GPR120 modulator 1
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Synthetic peptide – KLH conjugated (Immunogen sequence is commercially sensitive and details are not available)
Antigen Species:
Species Reactivity: Human, Pig
Conjugation: Unconjugated
Storage Buffer: Phosphate-buffered saline, pH 7.4, containing 0.01% sodium azide
Storage Instruction: Keep as concentrated solution. Store at 4ºC short term. For extended storage aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/24899708?dopt=Abstract
